 |
Naratuximab emtansine |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-12 00:00:00 |
| Sponsor | Debiopharm International S.A.;Forum "apres-demain", Chemin Messidor 5-7, CP 5911; |
| |
Naratuximab emtansine |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-12 00:00:00 |
| Sponsor | Debiopharm International S.A.;Forum "apres-demain", Chemin Messidor 5-7, CP 5911; |